Alhusseini Ayham, Hamsho Suaad, Sleiay Mouhammed, Alsmoudi Hasan, Frzat Ayham, Alabdullah Hadi, Tawashi Yamama
Departments ofNeurology.
Rheumatology, Faculty of Medicine, Damascus University, Damascus.
Ann Med Surg (Lond). 2024 Jan 11;86(4):2154-2157. doi: 10.1097/MS9.0000000000001715. eCollection 2024 Apr.
Brucellosis, the most common microbial zoonotic disease in the world, is endemic in both industrialized and underdeveloped countries. Between 2 and 53% of patients with brucellosis, patients develop spondylitis, and people between the ages of 50 and 60 are the most commonly affected. It mostly affects the lumbar vertebrae (L4 and L5 in particular) and the thoracic vertebrae.
A 52-year-old patient was brought to the neurological clinic after complaining of lower back discomfort, reduced mobility, and lower extremity weakness for 6 weeks. Both the cervical and lumbar columns were the sites of the specific discomfort. MRI showed cervical and lumbar discitis.
A high titre of anti-brucella antibodies was found by serology testing. He was treated with oral doxycycline (100 mg, two times daily), rifampicin (900 mg) orally once daily, and gentamicin (400 mg) once daily. The patient had massive improvement after 3 months of treatment.
This case should serve as a reminder to healthcare providers to keep a high index of suspicion for uncommon infections, including Brucella species, in patients exhibiting discitis symptoms, especially when traditional microbiological gram stain and culture are negative.
布鲁氏菌病是世界上最常见的微生物源性人畜共患病,在工业化国家和不发达国家均为地方病。布鲁氏菌病患者中有2%至53%会发生脊柱炎,50至60岁的人群最常受累。该病主要影响腰椎(尤其是L4和L5)和胸椎。
一名52岁患者在主诉下背部不适、活动能力下降和下肢无力6周后被送至神经科诊所。颈椎和腰椎均为特定不适部位。磁共振成像显示颈椎和腰椎椎间盘炎。
血清学检测发现抗布鲁氏菌抗体滴度很高。对其采用口服强力霉素(100毫克,每日两次)、利福平(900毫克)每日口服一次以及庆大霉素(400毫克)每日一次进行治疗。治疗3个月后患者有显著改善。
该病例应提醒医疗服务提供者,对于表现出椎间盘炎症状的患者,尤其是传统微生物革兰氏染色和培养结果为阴性时,要高度怀疑包括布鲁氏菌属在内的不常见感染。